Press release
Pneumonia Testing Market Growth Drivers, Business Strategies and Future Prospects (2022-2027)
Pneumonia is one of the leading causes of fatalities in the world. As of 2019, the disease caused over 2.5 million deaths globally. Alarmingly, this toll grew even higher during the COVID-19 pandemic as the virus primarily targeted lungs. Such conditions pushed the healthcare industry stakeholders to develop faster and more effective methods of pneumonia diagnosis. The global pneumonia testing market is growing at a sound pace owing to such market trends. Point-of-care (POC) is being adopted rapidly as it is a fast, cost-effective, and accurate pneumonia testing method. It is enabling healthcare professionals to diagnose the disease in time. In addition, technologies such as enzyme-linked immunosorbent assay (ELISA) are further improving the effectiveness of the testing methods. Such factors are cumulatively leading the global pneumonia testing market to fruition.Get a sample copy of global pneumonia testing market:
https://www.fairfieldmarketresearch.com/report/pneumonia-testing-market/request-sample
Robust Adoption of Point-of-Care (POC) Testing to Sustain Global Pneumonia Testing Market Expansion
Market players in the global pneumonia testing market are consistently aiming to improve healthcare delivery. To this end, point-of-care (POC) testing is gaining traction as it aids healthcare professionals in swiftly identifying pneumonia. This testing method is favoured as a quicker diagnosis of pneumonia is desirable for timely treatment. As the prevalence of pneumonia keeps growing, the employment of the POC testing method is projected to increase substantially. A growing number of consumers are also preferring this testing method as it is cost-effective and faster than traditional pneumonia tests. Such a business landscape is expected to lead the global pneumonia testing market to sound growth.
Tech Innovations such as Enzyme-Linked Immunosorbent Assay (ELISA) Creating New Growth Possibilities
The rising incidence of pneumonia is incentivising rapid research and development activities to improve the quality of healthcare services. The enzyme-linked immunosorbent assay (ELISA) is one such technology that is poised to dominate the global pneumonia testing market. Several diseases including dengue, hepatitis, neurological disorders, AIDS, and cancer is contributing to significant demand for ELISA. The technology finds its application in vaccine development, toxicology, immunology, transplantation, drug monitoring, pharmaceuticals, cancer, and protein quantification among others. As the overall healthcare infrastructure improves, the penetration of such technologies is expected to proliferate. Against this backdrop, the global pneumonia testing market is projected to grow tremendously.
Presence of Robust Healthcare Infrastructure to Establish North America as Market Leader
The rising incidence of chronic diseases, potent healthcare infrastructure, and higher healthcare expenditure are some of the key reasons behind North America's dominance in the pneumonia testing market. Moreover, the region was one of the worst affected regions during the COVID-19 pandemic. This has rejuvenated the general public's focus on healthcare, persuading them to get tested early on. On the other end of the globe, Asia Pacific is also showcasing an upsurge in the pneumonia testing market. This is mainly due to improvements in healthcare technology outreach and high pneumonic fatalities among children under five years of age in the region.
Do You Have Any Query Or Specific Requirement? Request Customization of Report:
https://www.fairfieldmarketresearch.com/report/pneumonia-testing-market/request-customization
Prominent Market Players
The most competitive entities participating in the global pneumonia testing market include Abbott Laboratories, Thermofischer Inc, F.hoffman La Roche, Biomerieux SA, Hologic Inc, Bio-Rad Laboratories, Quidel Corporation, AdvanDx, Beckman Coulter, and Beckton and Dickinson Company.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA +1 (844) 3829746 (Toll-free)
Email: sales@fairfieldmarketresearch.com
Web: https://www.fairfieldmarketresearch.com/
Follow Us: https://bit.ly/3voYIm9
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pneumonia Testing Market Growth Drivers, Business Strategies and Future Prospects (2022-2027) here
News-ID: 2730852 • Views: …
More Releases from Fairfield Market Research
Small Modular Reactor (SMR) Market Set to Climb from $6.6 Bn in 2025 to $9.2 Bn …
The Small Modular Reactor (SMR) industry is entering a crucial phase of global development as nations accelerate the transition toward low-carbon energy systems and resilient power infrastructure. With the market estimated at US$ 6.6 billion in 2025 and projected to reach US$ 9.2 billion by 2032, the sector is expanding at a 4.9% CAGR during the forecast period. SMRs are emerging as a transformative alternative to traditional nuclear plants, offering…
Antimony-free Films Market Set for Sustainable Expansion Through 2032
The global Antimony-free Films Market is entering a defining phase of strategic expansion as sustainability, regulatory shifts, and consumer safety expectations reshape the packaging and materials landscape. With rising concerns surrounding antimony-based catalysts in polyester films, end-use industries are accelerating the transition toward safer, more compliant, and environmentally responsible alternatives. According to industry estimates, the market is valued at US$ 238.6 million in 2025 and is projected to reach US$…
Perovskite Photovoltaics Market Set for Transformational Growth Through 2032
The Perovskite Photovoltaics Market is entering a pivotal phase of commercialization and global expansion as emerging solar technologies gain momentum across residential, commercial, and utility-scale applications. Valued at USD 316.7 million in 2025 and projected to reach USD 4,435.6 million by 2032, the sector is expected to advance at a compelling 45.8% CAGR during the forecast period. This remarkable growth trajectory reflects rising demand for low-cost, high-efficiency solar modules, continued…
Micro EV Market Accelerates Toward a Sustainable Urban Mobility Future Through 2 …
The Micro Electric Vehicle (Micro EV) Market is entering a new phase of accelerated growth, supported by global sustainability targets, rapid urbanization, and policy-driven adoption of small-format electric mobility solutions. Valued at USD 12.1 billion in 2025 and projected to reach USD 26.8 billion by 2032, the industry expands at a 12.0% CAGR, reflecting strong market confidence in compact, zero-emission vehicles. These vehicles-ranging from two-seater microcars to lightweight quadricycles-are increasingly…
More Releases for Pneumonia
Nosocomial pneumonia, which is acquired in hospitals, and pneumonia linked to ve …
Hospital-acquired pneumonia (HAP), also known as nosocomial pneumonia, is a severe lung infection that develops 48 hours or more after hospital admission, often associated with invasive procedures such as mechanical ventilation. It is one of the most common healthcare-associated infections, contributing significantly to morbidity, mortality, and healthcare costs.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72903
With the rise of antibiotic resistance, aging populations, and increased use of ventilators in…
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
